Finally, gain-of-function (GOF) mutations in PCSK9, a protein involved in the fine-tuning of LDLr expression at the plasma membrane, account for 1% of FH cases by an increased lysosomal degradation of the LDLr [3]. This evidence concerns the gene PCSK9 and familial hyperaldosteronism.